Mesoblast Ltd (MESO) Stock Price, Quote, News & History

MESONASDAQ
$14.87
0.463.19%
At close: Sep 16, 5:00 PM EST
$14.71
0.302.08%
Pre-Market: 4:09 AM EST

Mesoblast (MESO) Stock Price, Quote, News & History | Benzinga

Loading...

Key Statistics

Open
-
Close
$14.87
Volume / Avg.
28.00 / 230.00K
Day Range
- - -
52 Wk Range
13.05 - 21.50
Market Cap
$1.91B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
43
Short Interest
3.33%
Days to Cover
13.49

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-
Investing Cash Flow (TTM)
-1.02M
Financing Cash Flow (TTM)
-15.33M
Free Cash Flow (TTM)
-44.73M
Capital Expenditure (TTM)
-898.00K
Net Change in Cash (TTM)
-60.18M

Analyst Trends and Forecast

1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$1.98B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
16.02
PB Ratio (TTM)
3.40
Earnings Yield % (TTM)
-2.98%
Earnings Yield % (FWD)
-2.14%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$4.38

Company Debt

Total Debt
$119.24M
LT Debt
$108.64M
LT Debt Issuance (TTM)
$121.35M
LT Debt Repayment (TTM)
-$127.29M
Total Cash
$47.39M
Debt to Equity
0.22
Issuance of Debt (TTM)
-$5.94M
Repayment of Debt (TTM)
-$127.29M

Key Statistics

Open
-
Close
$14.87
Volume / Avg.
28.00 / 230.00K
Day Range
- - -
52 Wk Range
13.05 - 21.50
Market Cap
$1.91B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
43
Short Interest
3.33%
Days to Cover
13.49

About

Sector
Health Care
Industry
Biotechnology
Mesoblast Ltd is a commercial-stage biotechnology company engaged in developing and commercializing allogeneic (off-the-shelf) cellular medicines for severe inflammatory conditions. Its commercial product, Ryoncil (remestemcel-L-rknd), is FDA-approve...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Mesoblast (MESO) stock?

A

You can purchase shares of Mesoblast (NASDAQ:MESO) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for Mesoblast (MESO) stock?

A

Mesoblast has a consensus price target of $25.50.

Q

What is the current price for Mesoblast (MESO)?

A

The stock price for Mesoblast (NASDAQ: MESO) is $14.71 last updated September 17, 2026 at 8:58 AM EDT.

Q

Does Mesoblast (MESO) pay a dividend?

A

There are no upcoming dividends for Mesoblast.

Q

When is Mesoblast (NASDAQ:MESO) reporting earnings?

A

Mesoblast does not have any upcoming earnings scheduled.

Q

Is Mesoblast (MESO) going to split?

A

There is no upcoming split for Mesoblast.

Q

What sector and industry does Mesoblast (MESO) operate in?

A

Mesoblast is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.